DUOS Launches Connections for a Cause to Support Local Communities Across the U.S.

DUOS, a digital health company empowering older adults to live independently and attain the highest level of health in partnership with health plans, today announced the launch of its latest initiative, Connections for a Cause.

UofL Health Selects Verato to Support Accurate Identity Management

Verato, the identity experts for healthcare, today announced that UofL Health, a fully integrated regional academic health system, will partner with Verato to deploy Verato’s healthcare master data management (hMDM) solution to support accurate identity management across UofL Health’s entire enterprise.

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

Eligo Bioscience, a pioneering gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.

AI Pioneer Rainbird Technologies Names Klick Health as Its Exclusive North American Life Sciences Partner

Rainbird Technologies and Klick Health today announced an exclusive, new partnership that will bring Rainbird’s proven Decision Intelligence platform to life sciences companies across North America, reinforcing both companies’ success working in highly regulated industries.

New Research From K Health: AI Can Improve Hypertension Treatment in Primary Care Settings

Artificial Intelligence (AI)-driven Primary Care company K Health announces today the publication of its peer-reviewed research in Mayo Clinic Proceedings: Digital Health, which demonstrates how K Health’s AI can provide information that allows for more personalized hypertension treatment in patient-facing settings.

Lightning Step Offers Enhanced Access and Support for Individuals with Substance Use Disorder Through Partnership with CHESS Health

Lightning Step, a leading provider of All-In-One CRM, EMR, and RCM solutions for behavioral health and addiction treatment facilities, is enhancing its platform with vital recovery support and alumni engagement for those contending with Substance Use Disorder (SUD).

Empatica Announces Plans for Landmark Clinical Study to Develop an AI-Based Seizure Forecast Based on Wearable Real-World Data

First-of-its-Kind Study will Use FDA-Cleared Wearable Technology to Better Understand and Predict SeizuresBOSTON--(BUSINESS WIRE)--Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitorin...

Yale New Haven Health Advances Breast Cancer Screening Goals with Commure

Through Commure Engage, Yale New Haven Health Automates Personalized Patient Outreach, Boosts Rates of Breast Cancer ScreeningsSAN FRANCISCO--(BUSINESS WIRE)--#commure--Commure Engage (formerly known as Rx.Health), a leading digital health and clinica...

GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis

GE HealthCare announced an industry-first US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax (PTX) algorithm for the detection, notification, triage and diagnosis of PTX.

RapidAI Announces a Series of Industry Firsts – Unique Rapid Edge Cloud Platform, Breakthrough AI Non-Contrast CT Suite, International Expansion in Japan

RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, is proud to announce major milestones in advancing its industry-leading deep clinical AI.